Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections

Mucosal Immunology

Volumn 6, Issue 5, 2013, Pages 900-910

  Hernandez Santos N ^a   Huppler, A R ^a   Peterson, A C ^a   Khader, S A ^b   McKenna, K C ^a   Gaffen, S L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 17; RAG1 PROTEIN;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CANDIDA ALBICANS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; FEMALE; FUNGAL CLEARANCE; FUNGAL VIABILITY; FUNGUS IMMUNITY; IMMUNE DEFICIENCY; IMMUNOREGULATION; KNOCKOUT MOUSE; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; OROPHARYNX CANDIDIASIS; PATHOGEN CLEARANCE; PRIORITY JOURNAL; TH1 CELL; TH17 CELL;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, MUCOSAL; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOUTH MUCOSA; OROPHARYNX; T-LYMPHOCYTE SUBSETS; TH17 CELLS;

EID: 84883176275     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.128     Document Type: Article

References (59)

1. Dongari-Bagtoglou, A. & Fidel, P. The host cytokine responses and protective immunity in oropharyngeal candidiasis. J. Dent. Res. 84, 966-977 (2005
2. Klein, R.S., Harris, C.A., Small, C.B., Moll, B., Lesser, M. & Friedland, G.H. Oralcandidiasis inhigh-riskpatients as the initialmanifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med. 311, 354-358 (1984
3. Dong, C. Diversification of T-helper-cell lineages: Finding the family root of IL-17-producing cells. Nat. Rev. Immunol. 6, 329-333 (2006
4. Steinman, L. A brief history of T(H)17, the first major revision in the T(H)1/ T(H)2 hypothesis of Tcell-mediated tissue damage. Nat.Med. 13, 139-145 (2007
5. Farah, C., Hu, Y., Riminton, S. & Ashman, R. Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene targeting. Oral Microbiol. Immunol. 21, 252-255 (2006
6. Conti, H. et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206, 299-311 (2009
7. Ho, A. et al. IL-17RC is required for immune signaling via an extended SEFIR domain in the cytoplasmic tail. J. Immunol. 185, 1063-1070 (2010
8. Lin, L. et al. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog. 5, e1000703 (2009
9. Wuthrich, M. et al. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J. Clin. Invest. 121, 554-568 (2011
10. Nanjappa, S.G., Heninger, E.,Wuthrich, M.,Gasper, D.J. & Klein, B.S. Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4(+) Tcells. PLoS Pathog. 8, e1002771 (2012
11. Zelante, T. et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37, 2695-2706 (2007
12. Acosta-Rodriguez, E.V. et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8, 639-646 (2007
13. Zielinski, C.E. et al. Pathogen-induced human T(H)17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484, 514-518 (2012
14. Huppler, A.R., Bishu, S. &Gaffen, S.L.Mucocutaneous candidiasis: The IL-17 pathway and implications for targeted immunotherapy. Arthritis Res. Ther. 14, 217 (2012
15. Klatt, N.R. & Brenchley, J.M. Th17 cell dynamics in HIV infection. Curr. Opin. HIV AIDS 5, 135-140 (2010
16. Chen, Z. et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. USA. 103, 8137-8142 (2006
17. Yang, X.O. et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282, 9358-9363 (2007
18. Freeman, A.F.& Holland, S.M. The hyper-IgE syndromes. Immunol. Allergy Clin. North Am. 28, 277-291. viii (2008
19. Ma, C.S. et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J. Exp. Med. 205, 1551-1557 (2008
20. Milner, J.D. et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452, 773-776 (2008
21. van de Veerdonk, F.L. et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N. Engl. J. Med. 365, 54-61 (2011
22. Liu, L. et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208, 1635-1648 (2011
23. Glocker, E.O. et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 361, 1727-1735 (2009
24. Plantinga, T.S. et al. Early stop polymorphism in human DECTIN-1 is associated with increased Candida colonization in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 49, 724-732 (2009
25. Puel, A. et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J. Exp. Med. 207, 291-297 (2010
26. Browne, S.K. & Holland, S.M. Immunodeficiency secondary to anticytokine autoantibodies. Curr. Opin. Allergy Clin. Immunol. 10, 534-541 (2010
27. Kisand, K. et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-Associated cytokines. J. Exp. Med. 207, 299-308 (2010
28. Puel, A. et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332, 65-68 (2011
29. Kamai, Y., Kubota, M., Kamai, Y., Hosokawa, T., Fukuoka, T. & Filler, S. New model of oropharyngeal candidiasis in mice. Antimicrob. Agents Chemother. 45, 3195-3197 (2001
30. Pearson, C., Uhlig, H.H. & Powrie, F. Lymphoid microenvironments and innate lymphoid cells in the gut. Trends Immunol. 33, 289-296 (2012
31. Buonocore, S. et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464, 1371-1375 (2010
32. Scurlock, A.M. et al. Interleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection. Infect. Immun. 79, 1349-1362 (2011
33. Bär, E. et al. A novel Th cell epitope of Candida albicans mediates protection from fungal infection. J. Immunol. 188, 5636-5643 (2012
34. Spellberg, B.J. et al. Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis. J Infect Dis 194, 256-260 (2006
35. Bozza, S. et al. Dendritic cell-based vaccination against opportunistic fungi. Vaccine 22, 857-864 (2004
36. Casadevall, A. & Pirofski, L.A. Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. Cell Host Microbe 11, 447-456 (2012
37. Tyznik, A.J., Sun, J.C. & Bevan, M.J. The CD8 population in CD4-deficient mice is heavily contaminated with MHC class II-restricted T cells. J. Exp. Med. 199, 559-565 (2004
38. Fidel, P.L. Jr. Candida-host interactions in HIV disease: Implications for oropharyngeal candidiasis. Adv. Dent. Res. 23, 45-49 (2011
39. Fenoglio, D. et al. Vd1 T lymphocytes producing IFN-gand IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood 113, 6611-6618 (2009
40. Nigam, P., Kwa, S., Velu, V. & Amara, R.R. Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection. J. Immunol. 186, 745-753 (2011
41. Lee, Y.K. et al. Late developmental plasticity in the T helper 17 lineage. Immunity 30, 92-107 (2009
42. Hirota, K. et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255-263 (2011
43. Pepper, M. et al. Different routes of bacterial infection induce longlived TH1 memory cells and short-lived TH17 cells. Nat. Immunol. 11, 83-89 (2010
44. Cua, D.J. & Tato, C.M. Innate IL-17-producing cells: The sentinels of the immune system. Nat. Rev. Immunol. 10, 479-489 (2010
45. Dungan, L.S. & Mills, K.H. Caspase-1-processed IL-1 family cytokines play a vital role in driving innate IL-17. Cytokine 56, 126-132 (2011
46. Kagami, S., Rizzo, H.L., Kurtz, S.E.,Miller, L.S. & Blauvelt, A. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J. Immunol. 185, 5453-5462 (2010
47. Quintin, J. et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12, 223-232 (2012
48. Herná ndez-Santos, N. & Gaffen, S.L. Th17 cells in immunity to Candida albicans. Cell Host Microbe 11, 425-435 (2012
49. Puel, A., Picard, C., Cypowyj, S., Lilic, D., Abel, L. & Casanova, J.L. Inborn errors of mucocutaneous immunity to Candida albicans in humans: A role for IL-17 cytokines?. Curr. Opin. Immunol. 22, 467-474 (2010
50. Iwakura, Y., Ishigame, H., Saijo, S. & Nakae, S. Functional specialization of interleukin-17 family members. Immunity 34, 149-162 (2011
51. Naglik, J. & Moyes, D. Epithelial cell innate response to Candida albicans. Adv. Dent. Res. 23, 50-55 (2011
52. Cheng, S.C. et al. Candida albicans dampens host defense by downregulating IL-17 production. J. Immunol. 185, 2450-2457 (2010
53. Kweon, M. Sublingual mucosa: A new vaccination route for systemic and mucosal immunity. Cytokine 54, 1-5 (2011
54. Bik, E.M. et al. Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J 4, 962-974 (2010
55. Ivanov, I.I. et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4, 337-349 (2008
56. Zelante, T., Iannitti, R., De Luca, A. & Romani, L. IL-22 in antifungal immunity. Eur J. Immunol. 41, 270-275 (2011
57. Pietrella, D. et al. Th17 cells and IL-17 in protective immunity to vaginal candidiasis. PLoS One 6, e22770 (2011
58. Lilly, E.A.,Yano, J.& Fidel,P.L. Jr. Annexin-A1 identified as the oral epithelial cell anti-Candida effector moiety. Mol. Oral.Microbiol. 25, 293-304 (2010
59. Yano, J., Lilly, E., Barousse, M. & Fidel, P.L. Jr. Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis. Infect Immun 78, 5126-5137 (2010